Cytotoxicity and biotransformation of the anticancer drug perillyl alcohol in PC12 cells and in the rat

被引:39
作者
Boon, PJM [1 ]
van der Boon, D [1 ]
Mulder, GJ [1 ]
机构
[1] Leiden Univ, Leiden Amsterdam Ctr Drug Res, Div Toxicol, NL-2300 RA Leiden, Netherlands
关键词
perillyl alcohol; apoptosis; PC12; cells; biotransformation of perillyl alcohol in the rat in vivo; biotransformation of perillyl alcohol in rat hepatocytes; glucuronidation of perillyl alcohol;
D O I
10.1006/taap.2000.8988
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The cytotoxic monoterpene perillyl alcohol (POH) has anticancer properties. We investigated its cytotoxicity in PC12 cells in relation to its biotransformation. POH is oxidized by alcohol dehydrogenase and aldehyde dehydrogenase to perillaldehyde (PCO) and perillic acid (PCOOH), respectively. Apoptosis was determined by cell cycle (subG(0)G(1)) analysis and AnfiexinV staining followed by flow cytometry. PCO caused apoptosis at 200 mu M, POH caused apoptosis from 500 PM on, while PCOOH had no effect. The caspase inhibitor zVAD prevented apoptosis. Inhibition of POH oxidation by 4-methylpyrazol did not prevent the apoptotic effect of POH indicating that POH itself is also apoptotic. To find out to what extent POH is metabolized to PCO, the metabolism of POH, PCO, and PCOOH was determined after intravenous injection in the rat and in isolated hepatocytes. Although PCO can form a glutathione conjugate(s), no indication of the formation of GSH conjugates was found either in vivo or in hepatocytes. About 70% of the dose was recovered as glucuronides in bile and urine. PCOOH generated only the acyl glucuronide, while POH and PCO formed both acyl and ether glucuronides, These results indicate that PCO is a major intermediary metabolite of POH in the rat in,vivo and suggest that PCO may contribute to the anticancer effect of POH. (C) 2000 Academic Press.
引用
收藏
页码:55 / 62
页数:8
相关论文
共 26 条
  • [1] Ariazi EA, 1999, CANCER RES, V59, P1917
  • [2] CROTEAU R, 1981, BIOSYNTHESIS ISOPREN, P225
  • [3] CROWELL PL, 1994, CANCER CHEMOTH PHARM, V35, P31, DOI 10.1007/s002800050189
  • [4] CROWELL PL, 1994, CRIT REV ONCOGENESIS, V5, P1
  • [5] CROWELL PL, 1991, J BIOL CHEM, V266, P17679
  • [6] STRUCTURE-ACTIVITY-RELATIONSHIPS AMONG MONOTERPENE, INHIBITORS OF PROTEIN ISOPRENYLATION AND CELL-PROLIFERATION
    CROWELL, PL
    REN, ZB
    LIN, SZ
    VEDEJS, E
    GOULD, MN
    [J]. BIOCHEMICAL PHARMACOLOGY, 1994, 47 (08) : 1405 - 1415
  • [7] INHIBITION OF DMBA-INDUCED MAMMARY-CANCER BY THE MONOTERPENE D-LIMONENE
    ELEGBEDE, JA
    ELSON, CE
    QURESHI, A
    TANNER, MA
    GOULD, MN
    [J]. CARCINOGENESIS, 1984, 5 (05) : 661 - 664
  • [8] ANTI-CARCINOGENIC ACTIVITY OF D-LIMONENE DURING THE INITIATION AND PROMOTION PROGRESSION STAGES OF DMBA-INDUCED RAT MAMMARY CARCINOGENESIS
    ELSON, CE
    MALTZMAN, TH
    BOSTON, JL
    TANNER, MA
    GOULD, MN
    [J]. CARCINOGENESIS, 1988, 9 (02) : 331 - 332
  • [9] THE INHIBITION OF PROTEIN PRENYLTRANSFERASES BY OXYGENATED METABOLITES OF LIMONENE AND PERILLYL ALCOHOL
    GELB, MH
    TAMANOI, F
    YOKOYAMA, K
    GHOMASHCHI, F
    ESSON, K
    GOULD, MN
    [J]. CANCER LETTERS, 1995, 91 (02) : 169 - 175
  • [10] HAAG JD, 1994, CANCER CHEMOTH PHARM, V34, P477, DOI 10.1007/BF00685658